Federal Contractor Profile
Health Decisions, INC.
Federal contracting record: $57M obligated across 21 awards from 1 agencies, FY 2016–2026.
Company Profile
Parent UEI (Unique Entity Identifier)
CMKQYLSLNJG1
CAGE Code
3FAM0
Address
2510 MERIDIAN PKWY, DURHAM, NC, 277132260
First Federal Award
Nov 19, 2015
Most Recent Award
Jul 30, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Health and Human Services$57M
100.0% of total obligations
Top NAICS Activity
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Sep 18, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | NICHD:R&D:CCTN STATISTICAL AND CLINICAL COORDINATING CENTER (SCCC) CORE FUNCTION ACTIVITIES:SEVERABLE | $495K |
| Sep 10, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION | $898K |
| Sep 1, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | $1.1M |
| May 13, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | $173K |
| Apr 22, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION" | $297K |
| Apr 1, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | $27K |
| Feb 23, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | $358K |
| Sep 16, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020. | $487K |
| Jul 25, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | $233K |
| May 21, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020. | $32K |
| Apr 30, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | $700K |
| Apr 21, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION | $70K |
| Apr 21, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION" | $607K |
| Dec 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION" | $271K |
| Dec 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION | $608K |
| Nov 27, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | $61K |
| Nov 14, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION | $24K |
| Sep 24, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING | $1.2M |
| Sep 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION | $783K |
| Sep 19, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS | $994K |
| Sep 17, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020. | $18K |
| Aug 30, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | $457K |
| Aug 27, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020. | $479K |
| Aug 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541715 | TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020. | $44K |
| Aug 14, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD | 541712 | IGF::OT::IGF EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS OF CONTRACEPTIVE EFFICACY AND SAFETY OF MULTIPURPOSE PREVENTION TECHNOLOGIES PRODUCTS | $432K |
Want to win work like Health Decisions, INC.?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.